Engineered viral nanoparticles for flow cytometry and fluorescence microscopy applications

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 4, Issue 5, 2012, Pages 511-524

  Robertson, Kelly L ^a   Liu, Jinny L ^a  

^a NAVAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL FIELDS; CARGO DELIVERY; CELL SURFACES; CELLULAR LOCALIZATION; FLUORESCENT REPORTER; VIRAL NANOPARTICLES;

CELL MEMBRANES; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMAGING TECHNIQUES;

NANOPARTICLES;

DYE; FOLIC ACID; GLYCAN; GREEN FLUORESCENT PROTEIN; NANOPARTICLE; TRANSFERRIN; UNCLASSIFIED DRUG; VIRAL NANOPARTICLE;

CELL LABELING; CELL MEMBRANE; CELL SURFACE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONJUGATION; ENZYME MECHANISM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE MUTATION; GENETIC ENGINEERING; ILLUMINATION; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; QUANTITATIVE ANALYSIS; REVIEW; SPECTROSCOPY;

FLOW CYTOMETRY; FLUORESCENT DYES; GENETIC ENGINEERING; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; VIRUSES;

EID: 84865330958     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1177     Document Type: Review

References (77)

1. Steinmetz NF. Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine 2010, 6:634-641.
2. Sánchez-Rodríguez SP, Münch-Anguiano L, Bustos-Jaimes I. Advances in the development of virus-like particles as tools in medicine and nanoscience. Curr Chem Biol 2010, 4:231-243.
3. Li K, HNguyen HG, Lu X, Wang Q. Viruses and their potential in bioimaging and biosensing applications. Analyst 2010, 135:21-27.
4. Soto CM, Ratna BR. Virus hybrids as nanomaterials for biotechnology. Curr Opin Biotechnol 2010, 21:426-438.
5. Singh P, Gonzalez MJ, Manchester M. Viruses and their uses in nanotechnology. Drug Dev Res 2006, 67:23-41.
6. Steinmetz N, Manchester M. Viral Nanoparticles Tools for Materials Science and Biomedicine. Singapore: Pan Stanford Publishing Pte. Ltd.; 2011.
7. Lakadamyali M, Rust MJ, Babcock HP, Zhuang X. Visualizing infection of individual inflenza viruses. Proc Natl Acad Sci U S A 2003, 100:9280-9285.
8. Vonderheit A, Helenius A. Rab7 associates with early endosomes to mediate sorting and transport of Semliki forest virus to late endosomes. PLos Biol 2005, 3:e233.
9. Barnhill HN, Reuther R, Ferguson PL, Dreher T, Wang Q. Turnip yellow mosaic virus as a chemoaddressable bionanoparticle. Bioconjug Chem 2007, 18:852-859.
10. Steinmetz NF, Mertens ME, Taurog RE, Johnson JE, Commandeur U, Fischer R, Manchester M. Potato virus X as a novel platform for potential biomedical applications. Nano Lett 2010, 10:305-312.
11. Robertson KL, Soto CM, Archer MJ, Odoemene O, Liu JL. Engineered T4 viral nanoparticles for cellular imaging and flow cytometry. Bioconjug Chem 2011, 22:595-604.
12. Li K, Chen Y, Siqi L, Nguyen HG, Hiu Z, You S, Mello CM, Lu X, Wang Q. Chemical modification of M13 bacteriophage and its application in cancer cell imaging. Bioconjug Chem 2010, 21:1369-1377.
13. Sapsford KE, Soto CM, Blum AS, Chatterji A, Lin T, Johnson JE, Ligler FS, Ratna BR. A cowpea mosaic virus nanoscaffold for multiplexed antibody conjugation: applications as an immunoassay tracer. Biosens Bioelectron 2006, 21:1668-1673.
14. Schlick TL, Ding Z, Kovacs EW, Francis MB. Dual-surface modification of the tobacco mosaic virus. J Am Chem Soc 2005, 127:3718-3723.
15. Bruckman MA, Kaur G, Lee LA, Xie F, Sepulveda J, Breitenkamp R, Zhang X, Joralemon M, Russell TP, Emrick T, et al. Surface modification of tobacco mosaic virus with "click" chemistry. ChemBioChem 2008, 9:519-523.
16. Mamidyala SK, Finn MG. In situ click chemistry: probing the binding landscapes of biological molecules. Chem Soc Rev 2010, 39:1252-1261.
17. Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed 2001, 40:2004-2021.
18. Pokorski JK, Steinmetz NF. The art of engineering viral nanoparticles. Mol Pharm 2011, 8:29-43.
19. Kaltgrad E, O'Reily MK, Liao L, Han S, Paulson JC, Finn MG. On-virus construction of polyvalent glycan ligands for cell-surface receptors. J Am Chem Soc 2008, 130:4578-4579.
20. Jennings GT, Bachmann MF. The coming of age of virus-like particle vaccines. Biol Chem 2008, 389:521-536.
21. Blum AS, Soto CM, Wilson CD, Cole JD, Kim M, Gnade B, Chatterji A, Ochoa WF, Lin T, Johnson JE, et al. Cowpea mosaic virus as a scaffold for 3-D patterning of gold nanoparticles. Nano Lett 2004, 4:867-870.
22. Blum AS, Soto CM, Wilson CD, Whitley JL, Moore MH, Sapsford KE, Lin T, Chatterji A, Johnson JE, Ratna BR. Templated self-assembly of quantum dots from aqeous solution using protein scaffolds. Nanotechnology 2006, 17:5073-5079.
23. Chatterji A, Ochoa W, Shamieh L, Salakian SP, Wong SM, Clinton G, Ghosh P, Lin T, Johnson JE. Chemical conjugation of heterologous proteins on the surface of cowpea mosaic virus. Bioconjug Chem 2004, 15:807-813.
24. Soto CM, Blum AS, Vora GJ, Lebedev N, Meador CE, Won AP, Chatterji A, Johnson JE, Ratna BR. Fluorescent signal amplification of carbocyanine dyes using engineered viral nanoparticles. J Am Chem Soc 2006, 128:5184-5189.
25. Wang Q, Lin T, Tang L, Johnson JE, Finn MG. Icosahedral virus particles as addressable nanoscale building blocks. Angew Chem Int Ed 2002, 41:459-462.
26. Smith ML, Lindbo JA, Dillard-Telm S, Brosio PM, Lasnik AB, McCormick AA, Nguyen LV, Palmer KE. Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications. Virology 2006, 348:475-488.
27. Venter PA, Dirksen A, Thomas D, Manchester M, Dawson PE, Schneemann A. Multivalent display of proteins on viral nanoparticles using molecular recognition and chemical ligation strategies. BioMacromolecules 2011, 12:2293-2301.
28. Manayani DJ, Thomas D, Dryden KA, Reddy V, Siladi ME, Marlett JM, Rainey GJA, Pique ME, Scobie HM, Yeager M, et al. A viral nanoparticle with dual function as an anthrax antitoxin and vaccine. PLoS Pathog 2007, 3:e142.
29. Morizono K, Xie Y, Helguera G, Daniels TR, Lane TF, Penichet ML, Chen ISY. A versatile targeting system with lentiviral vectors bearing the biotin-adaptor peptide. J Gene Med 2009, 11:655-663.
30. Charpilienne A, Nejmeddine M, Berois M, Parez N, Neumann E, Hewat E, Trugnan G, Cohen J. Individual rotavirus-like particles containing 120 molecules of fluorescent protein are visible in living cells. J Biol Chem 2001, 276:29361-29367.
31. Cortes-Perez NG, Sapin C, Jaffrelo L, Daou S, Grill JP, Philippe L, Seksik P, Beaugerie L, Chwetzoff S, Trugnan G. Rotavirus-like particles: a novel nanocarrier for the gut. J Biomed Biotechnol (Epub ahead of print; April 13, 2010).
32. Rao VB, Thaker V, Black LW. A phage T4 in vitro packagin system for cloning long DNA molecules. Gene 1992, 113:25-33.
33. Liu JL, Robertson KL, Soto CM. Novel bacteriophage T4 nanoparticles for biotechnology and sensor applications. Provisional Patent filed in 2011.
34. Ashley CE, Carnes EC, Phillips GK, Durfee PN, Buley MD, Lino CA, Padilla DP, Phillips B, Carter MB, Willman CL, et al. Cell-specific delivery of diverse cargos by bacteriophage MS2 virus-like particles. ACS Nano 2011, 5:5729-5745.
35. Loo L, Guenther RH, Lommel SA, Franzen S. Infusion of dye molecules into Red clover necrotic mosaic virus. Chem Commun 2008, 1:88-90.
36. Dixit SK, Coicochea NL, Marie-Christine D, Murali A, Bronstein LM, De M, Stein B, Rotello VM, Kao CC, Dragnea B. Quantum dot encapsulation in viral capsids. Nano Lett 2006, 6:1993-1999.
37. Loo L, Guenther RH, Lommel SA, Franzen S. Encapsidation of nanoparticles by Red Clover necrotic mosaic virus. J Am Chem Soc 2007, 129:11111-11117.
38. Lee KW, Tan WS. Recombinant hepatitis B virus core particles: association, dissociation and encapsidation of green fluorescent protein. J Virol Methods 2008, 151:172-180.
39. Minten IJ, Hendriks LJA, Nolte RJM, Cornelissen JJLM. Controlled encapsulation of multiple proteins in virus capsids. J Am Chem Soc 2009, 131:17771-17773.
40. Baumann RG, Mullaney J, Black LW. Portal fusion protein constraints on function in DNA packaging of bacteriophage T4. Mol Microbiol 2006, 61:16-32.
41. Black LW, Thomas JA. Condensed genome structure. In: Rossmann MG, Rao VB eds. Viral Molecular Machines. Springer; 2012, 469-487.
42. Rhee J-K, Hovlid M, Fielder JD, Brown SD, Manzenrieder F, Kitagishi H, Nycholat C, Paulson JC, Finn MG. Colorful virus-like particles: fluorescent protein packaging by the Qβ Capsid. BioMacromolecules 2011, 12:3977-3981.
43. Archer MJ, Liu JL. Bacteriophage T4 nanoparticles as materials in sensor applications: variables that influence their organization and assembly on surfaces. Sensors 2009, 9:6298-6311.
44. Olson NH, Gingery M, Eiserling FA, Baker TS. The structure of isometric capsids of bacteriophage T4. Virology 2001, 279:385-391.
45. Mujumdar RB, Ernst LA, Mujumdar SR, Lewis CJ, Waggoner AS. Cyanine dye labeling reagents: sulfoindocyanine succinimidyl esters. Bioconjug Chem 1993, 4:105-111.
46. Gruber HJ, Hahn CD, Kada G, Riener CK, Harms GS, Ahrer W, Dax TG, Knaus H-G. Anomalous fluorescence enhancement of Cy3 and Cy3.5 versus anomalous fluorescence loss of Cy5 and Cy7 upon covalent linking to IgG and noncovalent binding to avidin. Bioconjug Chem 2000, 11:696-704.
47. Yuan C-T, Chou W-C, Chen Y-N, Chou J-W, Chuu D-S, Lin C-AJ, Li JK, Chang WH, Shen J-L. Study of fluorescence enhancement of colloidal CdSe/ZnS quantum dots bound to hexadecylamine by single-molecule measurements. J Phys Chem C 2007, 111:15166-15172.
48. Jung B, Rao ALN, Anvari B. Optical nano-constructs composed of genome-depleted brome mosaic virus doped with a near infrared chromophore for potential biomedical applications. ACS Nano 2011, 5:1243-1252.
49. West W, Pearce S. The dimeric state of cyanine dyes. J Phys Chem 1965, 69:1894-1903.
50. West W, Pearce S, Grum F. Stereoisomerism in cyanine dyes-meso-substituted thiacarbocyanines. J Phys Chem 1967, 71:1316-1326.
51. Chen H, Ahsan SS, Santiago-Berrios MEB, Abruna HD, Webb WW. Mechanisms of quenching of Alexa fluorophores by natural amino acids. J Am Chem Soc 2010, 132:7244-7245.
52. Endo M, Fujitsuka M, Majima T. Porphyrin light-harvesting arrays constructed in the recombinant tobacco mosaic virus scaffold. Chem Eur J 2007, 13:8660-8666.
53. Miller RA, Presley AD, Francis MB. Self-assembling light-harvesting systems from synthetically modified tobacco mosaic virus coat proteins. J Am Chem Soc 2007, 129:3104-3109.
54. Samson M, Jung D. Intracellular trafficking and fate of chimeric adenovirus 5/F35 in human lymphocytes. J Gene Med 2011, 13:451-461.
55. Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. AccChem Res 2008, 41:120-129.
56. Chithrani BD, Ghazani AA, Chan WCW. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 2006, 6:662-668.
57. Drouin M, Cayer M-P, Jung D. Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor. Virology 2010, 401:305-313.
58. Lewis JD, Destito G, Zijlstra A, Gonzalez MJ, Quigley JP, Manchester M, Stuhlmann H. Viral nanoparticles as tools for intravital vascular imaging. Nat Med 2006, 12:354-360.
59. Koudelka KJ, Rae CS, Gonzalez MJ, Manchester M. Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus. J Virol 2007, 81:1632-1640.
60. Koudelka KJ, Destito G, Plummer EM, Trauger SA, Siuzdak G, Manchester M. Endothelial targeting of cowpea mosaic virus (CPMV) vis surface vimentin. PLOS Pathog 2009, 5:e1000417.
61. Robertson KL, Furukawa Y, Underwood A, Black LW, Liu JL. T4 Hoc and Soc deletion effects on physical properties and cellular uptake. Biochem Biophys Res Commun. 2012, 418:537-540.
62. Robertson K, Furukawa Y, Underwood A, Black L, Liu JL. Delection of the Hoc and Soc capsid proteins affects the surface and cellular uptake properties of bacteriophage T4 derived nanoparticles. Biochem Biophys Res Commun 2012, 418:537-540.
63. Salazar MD, Ratnam M. The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 2007, 26:141-152.
64. Rijnboutt S, Jansen G, Posthuma G, Hynes JB, Schornagel JH, Strous GJ. Endocytosis of GPI-linked membrane folate receptor-α. J Cell Biol 1996, 132:35-47.
65. Destito G, Yeh R, Rae CS, Finn MG, Manchester M. Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. Chem Biol 2007, 14:1152-1162.
66. Ren Y, Wong SM, Lim L-Y. Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. Bioconjug Chem 2007, 18:836-843.
67. Shan L, Xue J, Guo J, Qian Z, Achilefu S, Gu Y. Improved targeting of ligand-modified adenovirus as a new near infrared fluorescence tumor imaging probe. Bioconjug Chem 2011, 22:567-581.
68. Qian ZM, Li H, Sun H, Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 2002, 54:561-587.
69. Ryschich E, Huszty G, Knaebel HP, Hartel M, Büchler MW, Schmidt J. Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer 2004, 40:1418-1422.
70. Banerjee D, Liu AP, Voss NR, Schmid SL, Finn MG. Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles. ChemBioChem 2010, 11:1273-1279.
71. Huang RK, Steinmetz NF, Fu C-Y, Manchester M, Johnson JE. Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. Future Med 2011, 6:55-68.
72. Brunel FM, Lewis JD, Destito G, Steinmetz NF, Manchester M, Stuhlmann H, Dawson PE. Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting. Nano Lett 2010, 10:1093-1097.
73. Steinmetz NF, Ablack AL, Hickey JL, Ablack J, Manocha B, Symryk JS, Luyt LG, Lewis JD. Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing peptide receptors. Small 2011, 7:1664-1672.
74. Dube DH, Bertozzi CR. Glycans in cancer and inflammation - potential for therapeutics and diagnostics. Nat Rev Drug Discov 2005, 4:477-488.
75. Leong HS, Steinmetz NF, Ablack A, Destito G, Zijlstra A, Stuhlmann H, Manchester M, Lewis JD. Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles. Nat Protoc 2010, 5:1406-1417.
76. Strable E, Finn MG. Chemical modification of viruses and virus-like particles. Curr Top Microbiol Immunol 2009, 327:1-21.
77. Manchester M, Singh P. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. Adv Drug Deliv Rev 2006, 58:1505-1522.